DA Davidson Initiates Coverage On Cellebrite DI with Buy Rating, Announces Price Target of $20
Benzinga Newsdesk 5 months ago
NewsPrice TargetInitiationAnalyst Ratings
DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.
DA Davidson analyst Rudy Kessinger initiates coverage on Cellebrite DI (NASDAQ:CLBT) with a Buy rating and announces Price Target of $20.